mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
-0.34 |
0.07 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.07 |
mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.08 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.08 |